117 related articles for article (PubMed ID: 20708100)
1. Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism.
Jeon ES; Lee IH; Heo SC; Shin SH; Choi YJ; Park JH; Park DY; Kim JH
Biochim Biophys Acta; 2010 Nov; 1801(11):1205-13. PubMed ID: 20708100
[TBL] [Abstract][Full Text] [Related]
2. Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model.
Heo SC; Lee KO; Shin SH; Kwon YW; Kim YM; Lee CH; Kim YD; Lee MK; Yoon MS; Kim JH
Biochim Biophys Acta; 2011 Dec; 1813(12):2061-70. PubMed ID: 21855581
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth.
Do EK; Kim YM; Heo SC; Kwon YW; Shin SH; Suh DS; Kim KH; Yoon MS; Kim JH
Int J Biochem Cell Biol; 2012 Nov; 44(11):2069-76. PubMed ID: 22903068
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.
Shin SH; Kim J; Heo SC; Kwon YW; Kim YM; Kim IS; Lee TG; Kim JH
Mol Cell Proteomics; 2012 Feb; 11(2):M111.012385. PubMed ID: 22159598
[TBL] [Abstract][Full Text] [Related]
6. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Cho M; Suh DS; Yoon MS; Chang CL; Jung JS; Kim JH
Stem Cells; 2008 Mar; 26(3):789-97. PubMed ID: 18065393
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI.
Lee MJ; Heo SC; Shin SH; Kwon YW; Do EK; Suh DS; Yoon MS; Kim JH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1869-77. PubMed ID: 23735324
[TBL] [Abstract][Full Text] [Related]
8. Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F₂α-mediated paracrine mechanism.
Lee MJ; Kim MY; Heo SC; Kwon YW; Kim YM; Do EK; Park JH; Lee JS; Han J; Kim JH
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2733-40. PubMed ID: 22962328
[TBL] [Abstract][Full Text] [Related]
9. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid promotes secretion of VEGF by increasing expression of 150-kD Oxygen-regulated protein (ORP150) in mesenchymal stem cells.
Wei H; Wang F; Wang X; Yang J; Li Z; Cong X; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1426-34. PubMed ID: 23707263
[TBL] [Abstract][Full Text] [Related]
12. LPA receptor1 antagonists as anticancer agents suppress human lung tumours.
Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A
Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.
Xu X; Prestwich GD
Cancer; 2010 Apr; 116(7):1739-50. PubMed ID: 20143443
[TBL] [Abstract][Full Text] [Related]
14. Adipose-derived stromal cell cluster with light therapy enhance angiogenesis and skin wound healing in mice.
Park IS; Chung PS; Ahn JC
Biochem Biophys Res Commun; 2015 Jul; 462(3):171-7. PubMed ID: 25911320
[TBL] [Abstract][Full Text] [Related]
15. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells.
Wei J; Yan W; Li X; Ding Y; Tai HH
Lung Cancer; 2010 Jul; 69(1):26-32. PubMed ID: 19853959
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis.
Song HY; Lee MJ; Kim MY; Kim KH; Lee IH; Shin SH; Lee JS; Kim JH
Biochim Biophys Acta; 2010 Jan; 1801(1):23-30. PubMed ID: 19733258
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of activation factors of endothelia and fibroblasts via lysophosphatidic acid signaling in a mouse lung cancer LL/2 cell line.
Tanabe E; Kitayoshi M; Hirane M; Araki M; Dong Y; Fukushima N; Tsujiuchi T
J Recept Signal Transduct Res; 2013 Oct; 33(5):286-90. PubMed ID: 23909436
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential.
Alt E; Yan Y; Gehmert S; Song YH; Altman A; Gehmert S; Vykoukal D; Bai X
Biol Cell; 2011 Apr; 103(4):197-208. PubMed ID: 21332447
[TBL] [Abstract][Full Text] [Related]
20. A549 cells as a model to study endogenous LPA
Carmona-Rosas G; Alfonzo-Méndez MA; Hernández-Espinosa DA; Romero-Ávila MT; García-Sáinz JA
Eur J Pharmacol; 2017 Nov; 815():258-265. PubMed ID: 28943105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
